Rapid and sustained remission of synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome with IL-23p19 antagonist (risankizumab).

Flora, Akshay; Holland, Richard; Smith, Annika; Frew, John W

Flora, Akshay; Holland, Richard; Smith, Annika; Frew, John W.

Afiliación

Flora A; University of New South Wales, Sydney, Australia.
Holland R; Ingham Institute of Applied Medical Research, Liverpool, Australia.
Smith A; The Skin Hospital, Darlinghurst, Australia.
Frew JW; Department of Rheumatology, Concord Repatriation General Hospital, Sydney, Australia.

JAAD Case Rep ; 14: 33-36, 2021 Aug.

Article en En | MEDLINE | ID: mdl-34258349

Palabras clave

HS, hidradenitis suppurativa; IL, interleukin; SAPHO; SAPHO, synovitis, acne, pustulosis, hyperostosis, and osteitis; TNF, tumor necrosis factor; Th, helper T; hidradenitis suppurativa; inflammation; interleukin-23; risankizumab

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: JAAD Case Rep Año: 2021 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google